Redeye updates its estimates following Sleep Cycle's preliminary Q4 2022 numbers. Moreover, we comment on Velvet Cichlid's announcement that it is not raising the SEK42.50 offer.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

© Modular Finance, source Nordic Press Releases